Long-term real-world effectiveness and safety of fingolimod over 5 years in Germany.

Tjalf ZiemssenMichael LangStephan SchmidtHolger AlbrechtLuisa KlotzJudith HaasChristoph LassekStefan LangVeronika E WinkelmannBenjamin EttleUlf Schulze-Topphoffnull null

Published in: Journal of neurology (2022)

PANGAEA demonstrated the sustained beneficial effectiveness and safety of fingolimod in the long-term real-world treatment of patients with RRMS.

Keyphrases

multiple sclerosis